Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Yoshiko Akamatsu

Yoshiko Akamatsu

individual
Ecosystem influencer

About

Yoshiko Akamatsu is a biopharmaceutical scientist known for biologics, antibody/protein engineering, and oncology/immunology research at AbbVie. A PEGS Summit speaker biography says she earned a PhD in Biophysics from Kyoto University, completed postdoctoral training at Harvard Medical School, served as an associate professor at the University of Tokushima, and later worked at PDL BioPharma, Facet Biotech, Abbott, and AbbVie. Public profiles and publications indicate she has held senior scientific and platform leadership roles in AbbVie's biologics and genetic medicine work.

Areas of interest

biotechbiologicsantibody engineeringprotein engineeringoncologyimmunologycancer immunotherapygenetic medicine